» Articles » PMID: 34341517

Mendelian Randomisation Study of Smoking Exposure in Relation to Breast Cancer Risk

Overview
Journal Br J Cancer
Specialty Oncology
Date 2021 Aug 3
PMID 34341517
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite a modest association between tobacco smoking and breast cancer risk reported by recent epidemiological studies, it is still equivocal whether smoking is causally related to breast cancer risk.

Methods: We applied Mendelian randomisation (MR) to evaluate a potential causal effect of cigarette smoking on breast cancer risk. Both individual-level data as well as summary statistics for 164 single-nucleotide polymorphisms (SNPs) reported in genome-wide association studies of lifetime smoking index (LSI) or cigarette per day (CPD) were used to obtain MR effect estimates. Data from 108,420 invasive breast cancer cases and 87,681 controls were used for the LSI analysis and for the CPD analysis conducted among ever-smokers from 26,147 cancer cases and 26,072 controls. Sensitivity analyses were conducted to address pleiotropy.

Results: Genetically predicted LSI was associated with increased breast cancer risk (OR 1.18 per SD, 95% CI: 1.07-1.30, P = 0.11 × 10), but there was no evidence of association for genetically predicted CPD (OR 1.02, 95% CI: 0.78-1.19, P = 0.85). The sensitivity analyses yielded similar results and showed no strong evidence of pleiotropic effect.

Conclusion: Our MR study provides supportive evidence for a potential causal association with breast cancer risk for lifetime smoking exposure but not cigarettes per day among smokers.

Citing Articles

Epidemiological breast cancer prediction by country: A novel machine learning approach.

El Haji H, Sbihi N, Guermah B, Souadka A, Ghogho M PLoS One. 2024; 19(8):e0308905.

PMID: 39141659 PMC: 11324133. DOI: 10.1371/journal.pone.0308905.


The relationship between smoking and rosacea: A Mendelian randomization study.

Cai Y, Zeng H, Tao M J Cosmet Dermatol. 2024; 23(12):4123-4128.

PMID: 39136194 PMC: 11626377. DOI: 10.1111/jocd.16498.


Global comparative transcriptomes uncover novel and population-specific gene expression in esophageal squamous cell carcinoma.

Alotaibi A, Gadekar V, Gundla P, Mandarthi S, Jayendra N, Tungekar A Infect Agent Cancer. 2023; 18(1):47.

PMID: 37641095 PMC: 10463703. DOI: 10.1186/s13027-023-00525-8.


Updates on Triple-Negative Breast Cancer in Type 2 Diabetes Mellitus Patients: From Risk Factors to Diagnosis, Biomarkers and Therapy.

Matou-Nasri S, Aldawood M, Alanazi F, Khan A Diagnostics (Basel). 2023; 13(14).

PMID: 37510134 PMC: 10378597. DOI: 10.3390/diagnostics13142390.


A Mendelian randomization study of the effect of tea intake on breast cancer.

Deng Y, Ge W, Xu H, Zhang J Front Nutr. 2022; 9:956969.

PMID: 36330145 PMC: 9623097. DOI: 10.3389/fnut.2022.956969.


References
1.
Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

2.
Hecht S . Tobacco smoke carcinogens and breast cancer. Environ Mol Mutagen. 2002; 39(2-3):119-26. DOI: 10.1002/em.10071. View

3.
PETRAKIS N, Gruenke L, Beelen T, Castagnoli Jr N, Craig J . Nicotine in breast fluid of nonlactating women. Science. 1978; 199(4326):303-5. DOI: 10.1126/science.619458. View

4.
PETRAKIS N, Maack C, Lee R, Lyon M . Mutagenic activity in nipple aspirates of human breast fluid. Cancer Res. 1980; 40(1):188-9. View

5.
Conway K, Edmiston S, Cui L, Drouin S, Pang J, He M . Prevalence and spectrum of p53 mutations associated with smoking in breast cancer. Cancer Res. 2002; 62(7):1987-95. View